Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Antibiot (Tokyo). 2014 Apr 16;67(8):549–553. doi: 10.1038/ja.2014.36

Figure 5. Anthracimycin protection of mice from MRSA mortality.

Figure 5

Female CD1 mice were infected intraperitoneally (~ 109 colony-forming units per mouse) with MRSA strain Sanger 252 and treated intraperitoneally one hour postinfection with either anthracimycin (1 or 10 mg/kg) or vehicle control (n = 10 mice per group). Survival was monitored over 7 days. These survival data are from one representative study that was repeated a total of two times.